摘要
目的分析海昆肾喜胶囊联合碳酸氢钠治疗慢性肾脏疾病的临床治疗效果。方法随机选取该院于2017年5月—2019年5月,此2年时间段内所收治的慢性肾脏疾病患者共计114例,将所有患者根据随机抽样的方式均分为实验组与对照组。其中实验组患者共57例,采用海昆肾喜胶囊联合碳酸氢钠治疗,对照组患者共57例,仅采用海昆肾喜胶囊治疗,分析比对两组研究对象经过治疗后其治疗效果情况。结果治疗结束后,实验组患者治疗有效率(98.2%)、Ccr水平(34.78±8.26)mL/min较对照组患者治疗有效率(89.5%)、Ccr水平(27.57±6.95)mL/min更高,且前者BUN(6.44±2.17)mmol/L、Scr(194.18±32.84)μmmol/L均较后者的BUN(10.38±3.09)mmol/L、Scr(211.67±38.45)μmmol/L更低,两组患者之间差异有统计学意义(P<0.05)。同时,实验组患者并发症发生率(3.5%)与对照组患者(1.8%)相差无几,两组患者间差异无统计学意义(P>0.05)。结论对于慢性肾脏疾病患者使用海昆肾喜胶囊联合碳酸氢钠进行治疗,可显著提升患者的治疗有效率与内生肌酐清除率,有效降低血尿素氮、血清肌酐水平,同时治疗后患者用药并发症发生率较低,是一种高效、安全的治疗方法。
Objective To analyze the clinical effect of Haikun Shenxi Capsule combined with sodium bicarbonate in the treatment of chronic kidney disease.Methods A total of 114 patients with chronic kidney disease treated in the hospital from May 2017 to May 2019 were randomly selected.All patients were divided into experimental group and control group according to the random sampling method.Among them,57 patients in the experimental group were treated with Haikun Shenxi Capsules combined with sodium bicarbonate,and 57 patients in the control group were treated with Haikun Shenxi Capsules only.The therapeutic effects of the two groups of subjects after treatment were analyzed and compared.Results After treatment,patients in the experimental group were more effective(98.2%)and Ccr(34.78±8.26)mL/min than patients in the control group(89.5%)and Ccr(27.57±6.95)mL/min,and the former BUN(6.44±2.17)mmol/L,Scr(194.18±32.84)μmmol/L were lower than the latter BUN(10.38±3.09)mmol/L,Scr(211.67±38.45)μmmol/L,the difference between the two groups of patients was statistically significant(P<0.05).At the same time,the incidence of complications in the experimental group(3.5%)was similar to that in the control group(1.8%),and there was no significant difference between the two groups(P>0.05).Conclusion For patients with chronic kidney disease,the use of Haikun Shenxi Capsules combined with sodium bicarbonate can significantly improve the treatment efficiency and endogenous creatinine clearance of patients,and effectively reduce blood urea nitrogen and serum creatinine levels.The incidence of complications is low,and it is an efficient and safe treatment method.
作者
刘玉平
LIU Yu-ping(Department of Nephrology,Juye County People's Hospital,Heze,Shandong Province,274900 China)
出处
《中外医疗》
2020年第16期112-114,共3页
China & Foreign Medical Treatment
关键词
海昆肾喜胶囊
慢性肾脏疾病
碳酸氢钠
Haikun Shenxi Capsule
Chronic kidney disease
Sodium bicarbonate
